Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US.
CURRENT MEDICAL RESEARCH AND OPINION（2018）
关键词
CML,metabolic outcomes,tyrosine kinase inhibitors,type 2 diabetes mellitus,hyperlipidemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要